Dean Health System   Report issue

Academic/Hospital Phase 4
Founded: WI United States (1904)

Organization Overview

First Clinical Trial
2006
NCT00478764
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Dean Health Systems

Active Ingredients

Drugs in Phase 4 Trials (1)

nicotine (nicorette) (3 trials)

Drugs in Other Trials (2)

gatifloxacin (Zymar) (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tobacco Use Disorder (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3